TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04197804

Intervention type: OTHER
Intervention: Routine tests perform
Description: The subjects of the Tourette group and control group are subjected to routine tests performed at Tourette Center and Extrapyramidal Diseases. Both groups are initially subjected to an evaluation that aims to identify the IQ and therefore 4 tasks are presented. The 1st (with a duration of about 2 and a half minutes) and the 2nd (with a duration of about 2 minutes) related to the motor field, the 3rd (with duration of about 1 minute) and the 4th (with duration about 3 minutes) the language field. These evaluations are in practice at the Center for Tourette patients; the tasks will be administered to both groups.
Study: NCT01976416

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT01110239

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: remote limb preconditioning
Description: 3 cycles of up to 10 minutes leg ischemia
Study: NCT02523417

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: interventional therapy
Description: breast cancer patients received HepaSphere interventional therapy using the digital subtraction angiography（DSA）

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: interventional therapy
Description: breast cancer patients received HepaSphere interventional therapy using the digital subtraction angiography（DSA）
Study: NCT04002765

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: pulmonary function tests
Description: 1. Lung function tests (standard of care)~   1. Dynamic and static volumes (FVC, FEV1, TPC, RV)~  2. Lung diffusion capacity for CO (DLCO)~2. Chest Xrays~3. High resolution CT scanner (HRCT)
Study: NCT04929301

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Antenatal milk expression
Description: Hand-expression of breast milk in pregnancy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education handouts
Description: Educational breastfeeding handouts
Study: NCT01276899

Intervention type: PROCEDURE
Intervention: Needle core biopsies
Description: No investigational products will be administered to subjects as part of this translational research study. Needle core biopsies will be done to collect tumor samples.~A taxane-based regimen will be administered as per the standard of care at each treating institution. Tissue samples from primary tumors will be collected and banked before the start of chemotherapy, after chemotherapy and at the time of surgery. Additionally, blood samples will be drawn before treatment initiation (baseline) and at different time points during treatment and stored in the tissue biobank.

Intervention type: PROCEDURE
Intervention: Needle core biopsies of metastatic lesion
Description: No investigational products will be administered to subjects as part of this translational research study. Needle core biopsies will be done to collect metastasis tumor samples.~Chemotherapy will be administered as per the standard of care at each treating institution. Tissue samples from metastatic tumors lesions will be collected and banked before the start of chemotherapy and at the time of progression. Additionally, blood samples will be drawn before treatment initiation (baseline) and at different time points during treatment and stored in the tissue biobank.
Study: NCT00963729

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: epirubicin hydrochloride
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fluorouracil
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: letrozole
Description: Given orally
Study: NCT00909805

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: cutaneous suture (Surjet)
Description: cutaneous surjet suture

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 2-octyl-cyanoacrylate (Dermabond® glue)
Description: the cutaneous suture is made with glue only
Study: NCT04713384

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Integrative tele-rehalitation of chronic stroke survivors using custom therapeutic games
Description: 20 sessions of playing therapeutic games using both arms while siting at a table at home. Arms hold either generic game controllers, or BrightBrainer therapeutic controllers. Sessions involve a variety of games that train motor and cognitive function in an integrative way. The games are rendered by the BrightBrainer system. Games adapt and are winnable, benefiting well-being (reducing depression). Each session may generate many hundreds of arm repetitions, finger movement and grasps, depending on session duration. Data on arm reach as well as game outcomes and vitals are uploaded to an secure server. These data allow researchers to remotely monitor compliance to protocol and longitudinal progress. Caregivers are present at each session, and provide feedback as well as subjective ratings of the system.
Study: NCT03779841

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-151607
Description: Injections were made into each 1 of 5 fat pads. The total injection volume into each fat pad was 1 mL. One-time treatment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-151607
Description: Injections were made into each 1 of 5 fat pads. The total injection volume into each fat pad was 1 mL. One-time treatment.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Injections of placebo were made into each 1 of 5 fat pads. The total injection volume into each fat pad was 1 mL. One-time treatment.
Study: NCT03772405

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nascum Plus
Description: nasal application of nascum plus

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ACC
Description: 4 hours challenge to grass pollen in the allergen challenge chamber (ACC)
Study: NCT03113682

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT-RD
Description: 5-8 sessions of cognitive behavioral therapy for rumination disorder (CBT-RD), held once per week in an outpatient setting.
Study: NCT04102358

Intervention type: PROCEDURE
Intervention: Medial approach infraclavicular block with single injection
Description: infraclavicular blocks performed with single injection

Intervention type: PROCEDURE
Intervention: Medial approach infraclavicular block with triple injection
Description: infraclavicular blocks performed with triple injection
Study: NCT01912248

Intervention type: OTHER
Intervention: strength training
Description: strength training, lower limb.

Intervention type: OTHER
Intervention: strength training
Description: strength training, lower limb.

Intervention type: OTHER
Intervention: strength training
Description: strength training, lower limb.
Study: NCT02513589

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-PBR06
Description: Positron Emission Tomography / Computed Tomography (PET-CT) using 18F-PBR06
Study: NCT03723694

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: 650 mg of Cocoapro flavanols
Description: 12-week period during which participant will be asked to consume two cocoa-flavanol-containing capsules(650mg) twice a day with meals.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: 0 mg of Cocoapro flavanols
Description: 12-week period during which participant will be asked to consume two cocoa-flavanol-containing capsules(0mg) twice a day with meals.
Study: NCT06664580

Intervention type: OTHER
Intervention: Metabolic Bariatric Surgery Procedures
Description: Observational analysis of various metabolic bariatric surgeries, including LSG, RYGB, and OAGB, focusing on long-term outcomes related to weight maintenance, nutritional health, and patient satisfaction.
Study: NCT00959075

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin B1
Description: 100 mg Twice a day

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sugar pill
Study: NCT03620851

Intervention type: OTHER
Intervention: effect of age
Description: effect of age on the efficiency of enhanced recovery program
Study: NCT01223716

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Perceptual learning
Description: Research participants will be asked to practice a visual discrimination task (e.g. position acuity, contrast sensitivity, stereoacuity etc) in our laboratory for a period of time (2 hrs/day, 5 days/week).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video Game
Description: Research participants will be asked to play off-the-shelf video games in our laboratory for a period of time (2 hrs/day, 5 days/week).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Crossover (Occlusion therapy + Video Game)
Description: Phase 1. Research participants will be required to cover the good eye during the day in order to push the brain to use the amblyopic eye (2 hrs/day, 5 days/week for 2-4 weeks).~Phase 2. Research participants will be required to cover the good eye during the day in order to push the brain to use the amblyopic eye (2 hrs/day, 5 days/week for 2-4 weeks).
Study: NCT00535886

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Man-made Trans FA
Description: EA as 6% of total energy
Study: NCT01554917

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iguratimod
Description: taken orally, 2 tablets/day (bid)
Study: NCT02249065

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brimonidine
Study: NCT04968873

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cholecystectomy and common bile duct exploration
Description: During elective open cholecystectomy, a basal commcn dile duct (CBD) manometry was obtained immediately after cholecystectomy, with a 10 Fr. silicone T tube introduced into the cystic duct and connected to a glass manometer.
Study: NCT02010346

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early headgear treatment
Description: The treatment with headgear is done as early treatment, beginning at ages 7-8 (Arm 1), or later, durning the maximal growth (arm 2)
Study: NCT02689609

Intervention type: RADIATION
Intervention: Intensity-modulated radiation therapy
Description: All patients will receive intensity-modulated radiation therapy with or without chemotherapy as usual standard of care in our institution.
Study: NCT01242293

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 0.9% Saline with glucose 5%
Description: intravenous hydration at a rate of 125 ml per hour during labor

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ringer lactate
Description: intravenous hydration at a rate of 250 ml per hour during labor
Study: NCT00535886

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Natural Trans FA
Description: VA as 6% of total energy

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Oleic Acid
Description: OA as 6% of total energy
Study: NCT02084329

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Weighted Compression Vest
Study: NCT03826446

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgery
Description: laparoscopic and open complete mesocolic excision with central vascular ligation in right colon cancer.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgery
Description: laparoscopic and open complete mesocolic excision with central vascular ligation in right colon cancer.
Study: NCT04700592

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gabapentin versus Ketamine
Description: A Comparison of Gabapentin and Ketamine in Acute and Chronic Pain

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gabapentin versus Ketamine
Description: A Comparison of Gabapentin and Ketamine in Acute and Chronic Pain
Study: NCT02128841

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Description: Direct Factor Xa Inhibitor
Study: NCT00084695

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-thymocyte globulin
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-thymocyte globulin
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-thymocyte globulin
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-thymocyte globulin
Description: Given IV
Study: NCT05283655

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy
Description: hypnotherapy
Study: NCT00084695

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: busulfan
Description: Given orally
Study: NCT01607580

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: low-dose glucocorticoid Methylprednisolone
Description: patients receive low-dose glucocorticoid from day 5 post transplant
Study: NCT00084695

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: busulfan
Description: Given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fludarabine phosphate
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: melphalan
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone
Description: Given IV
Study: NCT01607580

Intervention type: DRUG
Group type: OTHER
Intervention: low-dose glucocorticoid Methylprednisolone
Description: patients receive low-dose glucocorticoid from day 5 post transplant
Study: NCT00084695

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Description: Patients undergo radiation therapy two times daily on days -7 to -4.
Study: NCT01242293

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ringer lactate - Controls
Description: intravenous hydration at a rate of 125 ml per hour during labor
Study: NCT01157793

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: r-hGH
Description: r-hGH at a dose of 0.15-1.00 mg/day administered for 48 weeks by s.c. route

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: r-hGH
Description: Initially no treatment for the first 24 weeks followed by administration of r-hGH at a dose of 0.15 1.00 mg/day for the next 24 weeks, by s.c. route
Study: NCT00194441

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bedside display of cerebral perfusion pressure information
Description: Continually updating highly visible color coded bar graph bedside computer display of cerebral perfusion pressure

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Bedside display of cerebral perfusion pressure information
Description: Continually updating highly visible color coded bar graph bedside computer display of cerebral perfusion pressure
Study: NCT01976026

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flow Diversion

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Best Standard Therapy
Study: NCT01735461

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium Carbonate
Description: There is a regimen for dietary supplement intake that will be provided to study participants.
Study: NCT04563663

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Posteriorization of the talus.
Description: Three sets of a 30-s grade IV anteroposterior mobilization.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Posteriorization of the talus.
Description: Three sets of a 30-s grade IV anteroposterior mobilization.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Posteriorization of the talus.
Description: Three sets of a 30-s grade IV anteroposterior mobilization.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Posteriorization of the talus.
Description: Three sets of a 30-s grade IV anteroposterior mobilization.
Study: NCT03813173

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: lymph node dissection
Description: The patient was operated under general anesthesia with cervical hyper extension. The affected side or bilateral glandular lobes were resected routinely, which was confirmed as PTC by frozen section. Then one or both central lymph node dissection were separately packed and sent for examination. Scope of lymph node dissection in central carotid region: hyoid bone at the upper border, anonymous artery at the lower border, bilateral common carotid artery at the inner edge, shallow from the superficial layer of deep cervical fascia, deep to the deep layer of deep cervical fascia (anterior fascia). The right recurrent laryngeal nerve (RLN) passes through the central area of the right neck and should be specially protected.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lymph node dissection
Description: The patient was operated under general anesthesia with cervical hyper extension. The affected side or bilateral glandular lobes were resected routinely, which was confirmed as PTC by frozen section. Then one or both central lymph node dissection were separately packed and sent for examination. Scope of lymph node dissection in central carotid region: hyoid bone at the upper border, anonymous artery at the lower border, bilateral common carotid artery at the inner edge, shallow from the superficial layer of deep cervical fascia, deep to the deep layer of deep cervical fascia (anterior fascia). The right recurrent laryngeal nerve (RLN) passes through the central area of the right neck and should be specially protected.
Study: NCT03501823

Intervention type: OTHER
Intervention: Photoacoustic tomography
Description: A non-invasive, safe modality that relies on light and sound to generate images.

Intervention type: OTHER
Intervention: Photoacoustic tomography
Description: A non-invasive, safe modality that relies on light and sound to generate images.
Study: NCT01962610

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ePCA and Pain keycept intervention
Description: Study designed ePCA and pain keycept interventions are embedded in electronic medical record during patient ED visit.
Study: NCT00632060

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual / Manipulative Therapy (M/MT)
Description: Subjects will receive M/MT twice a week for 4 weeks
Study: NCT01357837

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching Placebo
Description: 2 capsules of matching placebo once a day, in the morning, for a total of 28 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GRT6005
Description: 2 capsules containing a total of 75 µg GRT6005 once a day, in the morning, for a total of 28 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GRT6005
Description: 2 capsules containing a total of 200 µg GRT6005 once a day, in the morning, for a total of 28 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GRT6005
Description: 2 capsules containing a total of 400 µg GRT6005 once a day, in the morning, for a total of 28 days
Study: NCT00279435

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: visilizumab
Study: NCT01361789

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: parecoxib, valdecoxib, etoricoxib
Description: 40 mg parecoxib (Dynastat, Pfizer®) one hour before surgery and 40 mg valdecoxib (prodrug of parecoxib, Bextra, Pfizer®)were given 8 hour after surgery.~After retraction of parecoxib from the market:~Etoricoxib (Arcoxia, MSD) 120 mg given one hour before surgery

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: 8 mg IV
Study: NCT01892813

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination pharmacotherapy - Transdermal nicotine patch + nicotine lozenge
Description: Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Combination pharmacotherapy - Transdermal nicotine patch + bupropion
Description: Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination pharmacotherapy - Transdermal nicotine patch + bupropion
Description: Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tobacco quitline referral
Description: Participants assigned to this condition will receive a referral to their state tobacco quitline. The specific behavioral treatment that is provided will differ slightly depending upon the services available through the participant's state of residence.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored behavioral intervention
Description: Participants will receive a standard six session cognitive behavioral intervention for smoking cessation combined with supplemental treatment modules based on individual need and preference.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Alcohol use risk reduction
Description: Participants engaging in risky alcohol use may receive this six-session telephone-based behavioral intervention for reducing alcohol use.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral activation for depressive symptoms
Description: Participants with elevated depressive symptoms may receive this six-session telephone-based behavioral activation intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral management of postcessation weight gain
Description: Participants with concerns about gaining weight after quitting smoking may receive this six-session telephone-based behavioral self-management intervention designed to help attenuate post-cessation weight gain.
Study: NCT02191969

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Walk With Ease
Description: A self-directed walking intervention developed by the Arthritis Foundation. The intervention is a workbook that coaches participants through walking regularly at a safe, comfortable pace with the ultimate goal of walking at least 30 minutes a day five days a week.
Study: NCT02122939

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Escitalopram